NCT07117227View on ClinicalTrials.gov

Development and Validation of RCC Predicting Model With Emulated-target Trial

Not yet recruitingOBSERVATIONAL
Enrollment

4,700

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

July 16, 2028

Conditions
Renal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)Tumor ThrombusPrognosisPrognostic Cancer ModelReal World StudyObservational Study
Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER